Vital Care® Infusion Services is Now Dispensing Cuvitru™
August 11, 2022 | Brentwood, TN
Takeda© Pharmaceutical Company has selected the Vital Care Infusion Services into their limited distribution network for Cuvitru.
Vital Care is excited and proud to announce it is part of the limited distribution network for Cuvitru, a subcutaneous treatment for patients with primary immunodeficiency (PI). Cuvitru is an Immune Globulin Subcutaneous (Human) (IGSC), 20% Solution indicated as replacement therapy for PI in adult and pediatric patients two years of age and older.
“Vital Care is dedicated to expanding access to high-quality infusion therapy and driving better patient outcomes by providing local, safe, convenient, and professional infusion services. Being selected by Takeda to offer Cuvitru expands our ability to deliver the best treatment options to providers and patients across our network of pharmacies. With the addition of Cuvitru we can now offer patients access to every immune globulin product available in the US market,” said Logan Davis, PharmD, MBA, Vice President of Trade for Vital Care.
About Vital Care:
Vital Care has a team of highly specialized clinicians and professionals who understand the need for simple, convenient, safe, and caring infusion services. We are all committed to creating an exceptional experience every time. Through our network of over 80 infusion pharmacies, Vital Care services patients predominantly located in secondary, tertiary, and underserved communities across the country. Vital Care works closely with each provider to create an individualized treatment plan that offers seamless continuity of care. For more information, visit vitalcare.com.
About Takeda Pharmaceuticals:
Takeda is a patient-focused global biopharmaceutical company with an industry-leading plasma portfolio and unique rare disease expertise. To learn more about Takeda, visit takeda.com and to learn more about Cuvitru, visit cuvitru.com.